Literature DB >> 1900127

Time-related distribution profiles of sulfated glycosaminoglycans in cells, cell surfaces, and media of cultured rat liver fat-storing cells.

A M Gressner1.   

Abstract

Fat-storing cells (perisinusoidal lipocytes, Ito cells), the principal proteoglycan-producing cell type in liver, were maintained for various times in primary and secondary culture to monitor the amount and pattern of [35S]sulfate-labeled glycosaminoglycans (GAG) in the cells, on the cell surface, and in the medium. In parallel with the phenotypic modulation of fat-storing cells toward myofibroblast-like cells, intracellular GAG decrease progressively, whereas cell surface-bound and medium GAG increase several-fold. These changes are associated with time-dependent alterations of the pattern of GAG in the various compartments. Dermatan sulfate is the most prominent intracellular GAG type in primary cultures, but on the cell surface and in the medium chondroitin sulfate prevails and reaches almost 70% of all medium GAG in secondary cultures. The results point to a highly dynamic expression of the specific types of GAG in the cellular and extracellular compartments of fat-storing cell cultures that seems to accompany the spontaneous transformation into myofibroblast-like cells. The latter one is a mainly chondroitin sulfate-producing cell type, whereas the initial fat-storing cell generates predominantly dermatan sulfate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900127     DOI: 10.3181/00379727-196-43193

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

1.  Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.

Authors:  J P Iredale; G Murphy; R M Hembry; S L Friedman; M J Arthur
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

2.  Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype.

Authors:  Malte Buchholz; Hans A Kestler; Karlheinz Holzmann; Volker Ellenrieder; Wilhelm Schneiderhan; Marco Siech; Guido Adler; Max G Bachem; Thomas M Gress
Journal:  J Mol Med (Berl)       Date:  2005-06-23       Impact factor: 4.599

3.  Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis.

Authors:  Julia O Nagy; Mónika Gallai; Anna Sebestyén; Zsuzsa Schaff; Sándor Paku; András Jeney; Renato V Iozzo
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

4.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture.

Authors:  M V Apte; P S Haber; T L Applegate; I D Norton; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

Review 5.  Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.

Authors:  O A Gressner; R Weiskirchen; A M Gressner
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.